Sedentary behavior and cancer-an umbrella review and meta-analysis.

Cancer mortality Cancer prevention Meta-analysis Sedentary behavior Sitting time Umbrella review

Journal

European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062

Informations de publication

Date de publication:
May 2022
Historique:
received: 10 08 2021
accepted: 11 04 2022
pubmed: 26 5 2022
medline: 23 6 2022
entrez: 25 5 2022
Statut: ppublish

Résumé

Several systematic reviews and meta-analyses have summarized the association between sedentary behavior (SB) and cancer. However, the level of evidence and the potential for risk of bias remains unclear. This umbrella review summarized the current data on SB in relation to cancer incidence and mortality, with a particular emphasis on assessing the risk of bias. We searched PubMed, Web of Science and Cochrane Database for systematic reviews and meta-analyses on the association between SB and cancer incidence and mortality. We also searched for recent observational studies not yet included in existing meta-analyses. We re-calculated summary risk estimates for cancer incidence and mortality using random effects models. We included 14 meta-analyses covering 17 different cancer sites from 77 original studies. We found that high SB levels increase the risk for developing ovarian, endometrial, colon, breast, prostate, and rectal cancers, with relative risks of 1.29 (95% confidence interval (CI) = 1.08-1.56), 1.29 (95% CI = 1.16-1.45), 1.25 (95% CI = 1.16-1.33), 1.08 (95% CI = 1.04-1.11), 1.08 (95% CI = 1.00-1.17), and 1.07 (95% CI = 1.01-1.12), respectively. Also, we found an increased risk of cancer mortality of 1.18 (95% CI = 1.09-1.26). Most associations between SB and specific cancer sites were supported by a "suggestive" level of evidence. High levels of SB are associated with increased risk of several types of cancer and increased cancer mortality risk.

Identifiants

pubmed: 35612669
doi: 10.1007/s10654-022-00873-6
pii: 10.1007/s10654-022-00873-6
pmc: PMC9209390
doi:

Types de publication

Journal Article Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

447-460

Informations de copyright

© 2022. The Author(s).

Références

J Natl Cancer Inst. 2014 Jun 16;106(7):
pubmed: 24935969
Res Q Exerc Sport. 2007 Sep;78(4):293-306
pubmed: 17941534
J Nutr Health Aging. 2020;24(1):63-70
pubmed: 31886810
Int J Behav Nutr Phys Act. 2017 Jun 10;14(1):75
pubmed: 28599680
PLoS Biol. 2013 Jul;11(7):e1001609
pubmed: 23874156
Nat Commun. 2021 Jul 28;12(1):4579
pubmed: 34321471
Ann Epidemiol. 2015 Sep;25(9):687-97
pubmed: 26099193
J Clin Oncol. 2016 Dec 10;34(35):4225-4230
pubmed: 27903150
JAMA Oncol. 2020 Aug 1;6(8):1210-1217
pubmed: 32556069
Med Sport Sci. 2014;60:11-26
pubmed: 25226797
Int J Obes (Lond). 2017 Jan;41(1):186-193
pubmed: 27677618
BMJ. 2015 Jan 02;350:g7607
pubmed: 25555821
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Endocrinology. 2014 Aug;155(8):2820-30
pubmed: 24828613
JNCI Cancer Spectr. 2018 Nov;2(4):pky073
pubmed: 30740587
Cancer Prev Res (Phila). 2019 Oct;12(10):675-688
pubmed: 31362941
Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2000-8
pubmed: 23966580
Int J Epidemiol. 2013 Aug;42(4):1040-56
pubmed: 24062293
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
Cancer. 2020 Feb 15;126(4):861-869
pubmed: 31714596
Breast Cancer. 2021 Jan;28(1):48-59
pubmed: 32607943
Clin Trials. 2007;4(3):245-53
pubmed: 17715249
Eur Heart J. 2011 Mar;32(5):590-7
pubmed: 21224291
Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19313-7
pubmed: 24218581
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2691-709
pubmed: 20833969
Res Synth Methods. 2010 Apr;1(2):112-25
pubmed: 26061377
Evid Based Ment Health. 2018 Aug;21(3):95-100
pubmed: 30006442
Cancer Epidemiol Biomarkers Prev. 2021 Jun;30(6):1218-1228
pubmed: 33737302
J Clin Epidemiol. 2012 May;65(5):503-10
pubmed: 22265586
Cancer Epidemiol. 2015 Dec;39 Suppl 1:S1-10
pubmed: 26164654
Medicine (Baltimore). 2017 Jun;96(22):e7049
pubmed: 28562564
PLoS One. 2013 Oct 29;8(10):e78350
pubmed: 24205208
J Sport Health Sci. 2021 Sep;10(5):560-569
pubmed: 33878448
Cancer Causes Control. 2015 Oct;26(10):1467-76
pubmed: 26293240
Obesity (Silver Spring). 2010 Jun;18(6):1273-5
pubmed: 19875989
BMJ. 2017 Sep 21;358:j4008
pubmed: 28935701
Br J Sports Med. 2020 May;54(10):582-591
pubmed: 31296585
J Clin Oncol. 2015 Jan 10;33(2):180-8
pubmed: 25488967
Diabetes. 2009 Aug;58(8):1776-9
pubmed: 19470610
Cancer Causes Control. 2019 Nov;30(11):1183-1200
pubmed: 31471762
J Epidemiol. 2021 Dec 5;31(12):621-627
pubmed: 32963209
Stat Med. 2006 Oct 30;25(20):3443-57
pubmed: 16345038
Alzheimers Dement. 2017 Apr;13(4):406-418
pubmed: 27599208
Onco Targets Ther. 2017 Sep 27;10:4787-4794
pubmed: 29033590
J Natl Cancer Inst. 2015 Jul 01;107(9):
pubmed: 26134033
Br J Sports Med. 2019 Jul;53(14):886-894
pubmed: 29991570
Eur J Epidemiol. 2018 Sep;33(9):811-829
pubmed: 29589226
Eur J Cancer Prev. 2018 Jul;27(4):331-338
pubmed: 28538039
Prev Med. 2021 Jul;148:106535
pubmed: 33798533
BMJ. 2001 Jan 27;322(7280):226-31
pubmed: 11159626
Br J Cancer. 2009 Dec 1;101(11):1932-8
pubmed: 19861965
BMJ. 2017 Feb 28;356:j477
pubmed: 28246088
Med Sci Sports Exerc. 2018 Feb;50(2):266-276
pubmed: 28930863
Epidemiology. 2011 Jul;22(4):450-6
pubmed: 21490505
Cancer Sci. 2020 Mar;111(3):974-984
pubmed: 31925977
Arch Gynecol Obstet. 2016 Feb;293(2):239-46
pubmed: 26338721
United European Gastroenterol J. 2018 Oct;6(8):1144-1154
pubmed: 30288276
Physiology (Bethesda). 2016 Jul;31(4):258-69
pubmed: 27252161
Stat Med. 2016 May 20;35(11):1749-62
pubmed: 26646432
Br J Sports Med. 2020 Dec;54(24):1451-1462
pubmed: 33239350
Nature. 2002 Dec 19-26;420(6917):860-7
pubmed: 12490959
Res Synth Methods. 2012 Sep;3(3):214-23
pubmed: 26062164
Metabolism. 2019 Mar;92:121-135
pubmed: 30445141
Cell Death Dis. 2015 Dec 31;6:e2037
pubmed: 26720346
Br J Cancer. 2014 Nov 25;111(11):2202-3
pubmed: 24569462
Obes Rev. 2022 May;23(5):e13422
pubmed: 35068047
Eur J Epidemiol. 2021 Aug;36(8):769-780
pubmed: 33492550
Front Oncol. 2019 Feb 25;9:101
pubmed: 30859092
J Clin Oncol. 2013 Mar 1;31(7):876-85
pubmed: 23341510
Br J Cancer. 2021 Aug;125(4):593-600
pubmed: 34059803
Eur J Cancer. 2016 Dec;69:61-69
pubmed: 27816833
Eur J Epidemiol. 2019 Jun;34(6):543-546
pubmed: 30852716
Br J Cancer. 2014 Feb 4;110(3):817-26
pubmed: 24263062
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):882-9
pubmed: 24526287
J Phys Act Health. 2012 May;9(4):533-9
pubmed: 21946087
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Epidemiol. 2017 Dec 1;46(6):1797-1813
pubmed: 29025130
Med Sci Sports Exerc. 2016 Mar;48(3):439-48
pubmed: 26460631
Cancer Res Treat. 2021 Apr;53(2):497-505
pubmed: 33138348
PLoS One. 2014 Aug 25;9(8):e105709
pubmed: 25153314
Br J Cancer. 2018 Mar 20;118(6):920-929
pubmed: 29520109
BMJ. 2011 Jul 22;343:d4002
pubmed: 21784880

Auteurs

Rafael Hermelink (R)

Department of Epidemiology and Preventive Medicine, University of Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany. rafaelhermelink@web.de.
Department of Internal Medicine II-Gastroenterology, University Hospital Munich, Munich, Germany. rafaelhermelink@web.de.

Michael F Leitzmann (MF)

Department of Epidemiology and Preventive Medicine, University of Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.

Georgios Markozannes (G)

Department of Hygiene and Epidemiology, University of Ioannina, Ioannina, Greece.
Department of Epidemiology and Biostatistics, Imperial College London School of Public Health, London, UK.

Kostas Tsilidis (K)

Department of Hygiene and Epidemiology, University of Ioannina, Ioannina, Greece.
Department of Epidemiology and Biostatistics, Imperial College London School of Public Health, London, UK.

Tobias Pukrop (T)

Department of Haematology and Internal Oncology, University Hospital of Regensburg, Regensburg, Germany.

Felix Berger (F)

Department of Epidemiology and Preventive Medicine, University of Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.

Hansjörg Baurecht (H)

Department of Epidemiology and Preventive Medicine, University of Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.

Carmen Jochem (C)

Department of Epidemiology and Preventive Medicine, University of Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH